Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of ...
Nuclear Imaging
Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.
May 7, 2013 — UltraSPECT has announced its distribution agreement with PharmaLogic for the sale of UltraSPECT’s cardiac ...
May 2, 2013 — Inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, may be detected and ...
Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...
May 1, 2013 — Texas Children's Hospital is the first children's hospital in the United States to begin using a positron ...
April 29, 2013 — Navidea Biopharmaceuticals Inc. announced the peer-reviewed publication of results from a clinical ...
April 19, 2013 — Sen. Stan Bingham and Sen. Wesley Meredith have introduced a bill in the North Carolina legislature ...
April 12, 2013 — Lantheus Medical Imaging has entered into a new agreement with Fujifilm RI Pharma (FRI) to license and ...
April 11, 2013 — An estimated 5,000 nuclear medicine and molecular imaging professionals are expected to gather in June ...
April 8, 2013 — Atomic Energy of Canada Limited (AECL) will commence a 30-day planned shutdown for inspection and ...
April 5, 2013 — UCLA researchers have used a brain-imaging tool and stroke risk assessment to identify signs of ...
April 5, 2013 — Navidea Biopharmaceuticals Inc. announced that collaborators at Molecular Neuroimaging LLC (MNI) in New ...
April 4, 2013 — Two novel radiolabeled small molecules targeting prostate-specific membrane antigen (PSMA) have ...
April 3, 2013 — In vivo ventilation/perfusion (V/Q) imaging can detect early changes to the lung caused by cigarette ...
April 1, 2013 — Lantheus Medical Imaging Inc. announced a new supply contract with the Belgium-based Institute for ...
April 1, 2013 — Navidea Biopharmaceuticals Inc. announced U.S. Food and Drug Administration (FDA) approval of Lymphoseek ...
March 27, 2013 — Piramal Imaging SA, a division of Piramal Enterprises, announced that the U.S. Food and Drug ...
March 26, 2013 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) launched a new online resource for ...
March 25, 2013 — The LumaGEM Molecular Breast Imaging (MBI) business of Gamma Medica Inc. has been acquired through a ...
March 22, 2013 — GE Healthcare announced the U.S. Food and Drug Administration (FDA) approval of a new indication for ...
Defining disease processes by their cellular and molecular signatures has enabled molecular diagnosis and the ...